ENSG00000051341 |
POLQ |
basal cell carcinoma |
sequence_alteration |
18.97% (11/58) |
1 entry |
ENSG00000051341 |
POLQ |
colorectal adenocarcinoma |
sequence_alteration |
6.942% (79/1138) |
2 entries |
ENSG00000051341 |
POLQ |
breast ductal adenocarcinoma |
missense_variant |
9.589% (56/584) |
1 entry |
ENSG00000051341 |
POLQ |
colorectal adenocarcinoma |
frameshift_variant |
6.942% (79/1138) |
2 entries |
ENSG00000051341 |
POLQ |
colorectal adenocarcinoma |
stop_gained |
6.942% (79/1138) |
1 entry |
ENSG00000051341 |
POLQ |
basal cell carcinoma |
missense_variant |
18.97% (11/58) |
1 entry |
ENSG00000051341 |
POLQ |
lung adenocarcinoma |
missense_variant |
5.074% (62/1222) |
7 entries |
ENSG00000051341 |
POLQ |
breast ductal adenocarcinoma |
sequence_alteration |
9.589% (56/584) |
2 entries |
ENSG00000051341 |
POLQ |
lung adenocarcinoma |
sequence_alteration |
5.074% (62/1222) |
3 entries |
ENSG00000051341 |
POLQ |
colorectal adenocarcinoma |
missense_variant |
6.942% (79/1138) |
4 entries |
ENSG00000051341 |
POLQ |
HER2 Positive Breast Carcinoma |
missense_variant |
10.13% (16/158) |
2 entries |
ENSG00000051341 |
POLQ |
lung adenocarcinoma |
stop_gained |
5.074% (62/1222) |
2 entries |
ENSG00000051341 |
POLQ |
colon adenocarcinoma |
stop_gained |
5.263% (38/722) |
3 entries |
ENSG00000051341 |
POLQ |
Gallbladder Adenocarcinoma |
missense_variant |
4.274% (5/117) |
2 entries |
ENSG00000051341 |
POLQ |
head and neck squamous cell carcinoma |
stop_gained |
1.072% (8/746) |
1 entry |
ENSG00000051341 |
POLQ |
female breast carcinoma |
missense_variant |
2.046% (8/391) |
1 entry |
ENSG00000051341 |
POLQ |
cecum adenocarcinoma |
frameshift_variant |
7.2% (9/125) |
1 entry |
ENSG00000051341 |
POLQ |
nasopharyngeal squamous cell carcinoma |
missense_variant |
1.796% (3/167) |
1 entry |
ENSG00000051341 |
POLQ |
skin melanoma |
sequence_alteration |
4.86% (47/967) |
1 entry |
ENSG00000051341 |
POLQ |
oral squamous cell carcinoma |
frameshift_variant |
5.213% (11/211) |
1 entry |
ENSG00000051341 |
POLQ |
ovarian serous adenocarcinoma |
missense_variant |
0.5944% (4/673) |
2 entries |
ENSG00000051341 |
POLQ |
acute myeloid leukemia |
missense_variant |
1.103% (10/907) |
1 entry |
ENSG00000051341 |
POLQ |
prostate carcinoma |
missense_variant |
2.273% (11/484) |
2 entries |
ENSG00000051341 |
POLQ |
colon adenocarcinoma |
frameshift_variant |
5.263% (38/722) |
3 entries |
ENSG00000051341 |
POLQ |
esophageal adenocarcinoma |
missense_variant |
4.795% (21/438) |
1 entry |
ENSG00000051341 |
POLQ |
oral squamous cell carcinoma |
stop_gained |
5.213% (11/211) |
2 entries |
ENSG00000051341 |
POLQ |
lung adenocarcinoma |
conservative_inframe_deletion |
5.074% (62/1222) |
1 entry |
ENSG00000051341 |
POLQ |
squamous cell lung carcinoma |
sequence_alteration |
3.152% (26/825) |
1 entry |
ENSG00000051341 |
POLQ |
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
2 entries |
ENSG00000051341 |
POLQ |
gastric adenocarcinoma |
sequence_alteration |
4.48% (25/558) |
1 entry |
ENSG00000051341 |
POLQ |
squamous cell lung carcinoma |
stop_gained |
3.152% (26/825) |
2 entries |
ENSG00000051341 |
POLQ |
brain glioblastoma |
missense_variant |
0.54% (5/926) |
1 entry |
ENSG00000051341 |
POLQ |
melanoma |
missense_variant |
8.911% (9/101) |
3 entries |
ENSG00000051341 |
POLQ |
esophageal squamous cell carcinoma |
missense_variant |
2.219% (15/676) |
6 entries |
ENSG00000051341 |
POLQ |
head and neck squamous cell carcinoma |
sequence_alteration |
1.072% (8/746) |
1 entry |
ENSG00000051341 |
POLQ |
rectal adenocarcinoma |
missense_variant |
1.81% (4/221) |
2 entries |
ENSG00000051341 |
POLQ |
hairy cell leukemia |
missense_variant |
9.524% (2/21) |
1 entry |
ENSG00000051341 |
POLQ |
large cell lung carcinoma |
missense_variant |
22.22% (4/18) |
1 entry |
ENSG00000051341 |
POLQ |
head and neck squamous cell carcinoma |
missense_variant |
1.072% (8/746) |
3 entries |
ENSG00000051341 |
POLQ |
skin melanoma |
stop_gained |
4.86% (47/967) |
3 entries |
ENSG00000051341 |
POLQ |
skin melanoma |
missense_variant |
4.86% (47/967) |
4 entries |
ENSG00000051341 |
POLQ |
small cell lung carcinoma |
missense_variant |
4.012% (13/324) |
4 entries |
ENSG00000051341 |
POLQ |
clear cell renal carcinoma |
missense_variant |
0.7752% (10/1290) |
1 entry |
ENSG00000051341 |
POLQ |
bile duct adenocarcinoma |
conservative_inframe_deletion |
1.176% (5/425) |
1 entry |
ENSG00000051341 |
POLQ |
squamous cell lung carcinoma |
missense_variant |
3.152% (26/825) |
3 entries |
ENSG00000051341 |
POLQ |
colon adenocarcinoma |
missense_variant |
5.263% (38/722) |
6 entries |
ENSG00000051341 |
POLQ |
prostate carcinoma |
sequence_alteration |
2.273% (11/484) |
2 entries |
ENSG00000051341 |
POLQ |
bile duct adenocarcinoma |
missense_variant |
1.176% (5/425) |
1 entry |
ENSG00000051341 |
POLQ |
breast carcinoma |
stop_gained |
1.205% (17/1411) |
1 entry |
ENSG00000051341 |
POLQ |
hepatocellular carcinoma |
missense_variant |
2.109% (19/901) |
2 entries |
ENSG00000051341 |
POLQ |
breast carcinoma |
missense_variant |
1.205% (17/1411) |
2 entries |
ENSG00000051341 |
POLQ |
colon adenocarcinoma |
sequence_alteration |
5.263% (38/722) |
3 entries |
ENSG00000051341 |
POLQ |
cecum adenocarcinoma |
missense_variant |
7.2% (9/125) |
1 entry |
ENSG00000051341 |
POLQ |
oral squamous cell carcinoma |
missense_variant |
5.213% (11/211) |
3 entries |
ENSG00000051341 |
POLQ |
diffuse gastric adenocarcinoma |
sequence_alteration |
2.532% (2/79) |
1 entry |
ENSG00000051341 |
POLQ |
brain glioblastoma |
frameshift_variant |
0.54% (5/926) |
1 entry |
ENSG00000051341 |
POLQ |
angiosarcoma |
sequence_alteration |
7.692% (1/13) |
1 entry |
ENSG00000051341 |
POLQ |
Malignant Germ Cell Tumor |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000051341 |
POLQ |
multiple myeloma |
missense_variant |
2.273% (1/44) |
1 entry |
ENSG00000051341 |
POLQ |
diffuse gastric adenocarcinoma |
stop_gained |
2.532% (2/79) |
1 entry |
ENSG00000051341 |
POLQ |
breast phyllodes tumor |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000051341 |
POLQ |
central nervous system primitive neuroectodermal neoplasm |
stop_gained |
0.4505% (2/444) |
1 entry |
ENSG00000051341 |
POLQ |
bile duct adenocarcinoma |
frameshift_variant |
1.176% (5/425) |
1 entry |
ENSG00000051341 |
POLQ |
gastric intestinal type adenocarcinoma |
frameshift_variant |
3.529% (3/85) |
1 entry |
ENSG00000051341 |
POLQ |
esophageal squamous cell carcinoma |
sequence_alteration |
2.219% (15/676) |
1 entry |
ENSG00000051341 |
POLQ |
Gallbladder Adenocarcinoma |
sequence_alteration |
4.274% (5/117) |
1 entry |
ENSG00000051341 |
POLQ |
clear cell renal carcinoma |
frameshift_variant |
0.7752% (10/1290) |
1 entry |
ENSG00000051341 |
POLQ |
clear cell renal carcinoma |
conservative_inframe_deletion |
0.7752% (10/1290) |
1 entry |
ENSG00000051341 |
POLQ |
Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000051341 |
POLQ |
Merkel cell skin cancer |
missense_variant |
3.333% (1/30) |
1 entry |
ENSG00000051341 |
POLQ |
laryngeal squamous cell carcinoma |
missense_variant |
3.846% (1/26) |
1 entry |
ENSG00000051341 |
POLQ |
pancreatic ductal adenocarcinoma |
frameshift_variant |
3.495% (44/1259) |
1 entry |
ENSG00000051341 |
POLQ |
neoplasm |
missense_variant |
7.143% (2/28) |
1 entry |
ENSG00000051341 |
POLQ |
large cell lung carcinoma |
sequence_alteration |
22.22% (4/18) |
1 entry |
ENSG00000051341 |
POLQ |
Pancreatic Acinar Cell Carcinoma |
missense_variant |
5.0% (1/20) |
1 entry |
ENSG00000051341 |
POLQ |
hepatocellular carcinoma |
stop_gained |
2.109% (19/901) |
1 entry |
ENSG00000051341 |
POLQ |
ovarian mucinous adenocarcinoma |
missense_variant |
7.692% (1/13) |
1 entry |
ENSG00000051341 |
POLQ |
T-cell acute lymphoblastic leukemia |
missense_variant |
0.2632% (1/380) |
1 entry |
ENSG00000051341 |
POLQ |
blood vessel neoplasm |
missense_variant |
16.67% (1/6) |
1 entry |
ENSG00000051341 |
POLQ |
non-small cell lung carcinoma |
conservative_inframe_deletion |
3.226% (2/62) |
1 entry |
ENSG00000051341 |
POLQ |
colon carcinoma |
stop_gained |
25.0% (2/8) |
1 entry |
ENSG00000051341 |
POLQ |
non-small cell lung carcinoma |
missense_variant |
3.226% (2/62) |
1 entry |
ENSG00000051341 |
POLQ |
small cell lung carcinoma |
frameshift_variant |
4.012% (13/324) |
1 entry |
ENSG00000051341 |
POLQ |
chronic myelomonocytic leukemia |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000051341 |
POLQ |
adrenal cortex carcinoma |
missense_variant |
0.6098% (1/164) |
1 entry |
ENSG00000051341 |
POLQ |
mucosal melanoma |
missense_variant |
7.143% (1/14) |
1 entry |
ENSG00000051341 |
POLQ |
bile duct adenocarcinoma |
stop_gained |
1.176% (5/425) |
1 entry |
ENSG00000051341 |
POLQ |
colonic neoplasm |
missense_variant |
6.667% (1/15) |
1 entry |
ENSG00000051341 |
POLQ |
melanoma |
conservative_inframe_deletion |
8.911% (9/101) |
1 entry |
ENSG00000051341 |
POLQ |
ependymoma |
sequence_alteration |
2.174% (1/46) |
1 entry |
ENSG00000051341 |
POLQ |
colon carcinoma |
missense_variant |
25.0% (2/8) |
1 entry |